SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001145443-10-001846
Filing Date
2010-08-12
Accepted
2010-08-12 17:10:09
Documents
5
Period of Report
2010-06-30
Filing Date Changed
2010-08-12

Document Format Files

Seq Description Document Type Size
1 d27007_10-q.htm 10-Q 808182
2 d27007_ex31-1.htm EX-31.1 50815
3 d27007_ex31-2.htm EX-31.2 51006
4 d27007_ex32-1.htm EX-32.1 15317
5 d27007_ex32-2.htm EX-32.2 15227
  Complete submission text file 0001145443-10-001846.txt   942271
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 101011923
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10